Joel Isaacson & Co’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.44M | Buy |
20,884
+571
| +3% | +$39.4K | 0.06% | 134 |
|
|
2025
Q1 | $1.41M | Buy |
20,313
+100
| +0.5% | +$6.94K | 0.06% | 127 |
|
|
2024
Q4 | $1.74M | Hold |
20,213
| – | – | 0.08% | 108 |
|
|
2024
Q3 | $2.41M | Hold |
20,213
| – | – | 0.11% | 82 |
|
|
2024
Q2 | $2.89M | Buy |
20,213
+336
| +2% | +$48K | 0.15% | 65 |
|
|
2024
Q1 | $2.55M | Sell |
19,877
-459
| -2% | -$58.9K | 0.14% | 75 |
|
|
2023
Q4 | $2.1M | Hold |
20,336
| – | – | 0.13% | 76 |
|
|
2023
Q3 | $1.85M | Buy |
20,336
+732
| +4% | +$66.6K | 0.13% | 75 |
|
|
2023
Q2 | $1.59M | Buy |
19,604
+14,808
| +309% | +$1.2M | 0.11% | 86 |
|
|
2023
Q1 | $382K | Hold |
4,796
| – | – | 0.03% | 214 |
|
|
2022
Q4 | $325K | Buy |
+4,796
| New | +$325K | 0.03% | 231 |
|
|
2016
Q2 | – | Sell |
-21,046
| Closed | -$570K | – | 755 |
|
|
2016
Q1 | $570K | Buy |
+21,046
| New | +$570K | 0.13% | 78 |
|